NVDA

186.56

-0.61%↓

AVGO.US

346.17

-1.07%↓

ORCL

194.87

-1.14%↓

MU

285.63

-2.39%↓

CSCO

77

-0.54%↓

NVDA

186.56

-0.61%↓

AVGO.US

346.17

-1.07%↓

ORCL

194.87

-1.14%↓

MU

285.63

-2.39%↓

CSCO

77

-0.54%↓

NVDA

186.56

-0.61%↓

AVGO.US

346.17

-1.07%↓

ORCL

194.87

-1.14%↓

MU

285.63

-2.39%↓

CSCO

77

-0.54%↓

NVDA

186.56

-0.61%↓

AVGO.US

346.17

-1.07%↓

ORCL

194.87

-1.14%↓

MU

285.63

-2.39%↓

CSCO

77

-0.54%↓

NVDA

186.56

-0.61%↓

AVGO.US

346.17

-1.07%↓

ORCL

194.87

-1.14%↓

MU

285.63

-2.39%↓

CSCO

77

-0.54%↓

Search

CEVA Inc

Nyitva

SzektorTechnológia

21.44 -1.06

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

21.39

Maximum

21.64

Fő mutatók

By Trading Economics

Bevétel

1.2M

-2.5M

Értékesítés

2.7M

28M

P/E

Szektor átlag

237

56.104

Profit margin

-8.839

Munkavállalók

403

EBITDA

4.6M

317K

Ajánlások

By TipRanks

Ajánlások

Erős vétel

12 hónapos előrejelzés

+67.29% upside

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-82M

581M

Előző nyitás

22.5

Előző zárás

21.44

Hangulat hírek alapján

By Acuity

36%

64%

101 / 403 Rangsor szerint Technology

Technikai pontszám

By Trading Central

Bizalom

Very Strong Bearish Evidence

CEVA Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2025. dec. 31. 22:20 UTC

Fő piaci mozgatók

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

2025. dec. 31. 17:31 UTC

Fő piaci mozgatók

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

2025. dec. 31. 16:30 UTC

Fő piaci mozgatók

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

2025. dec. 31. 15:19 UTC

Fő piaci mozgatók

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

2025. dec. 31. 15:17 UTC

Fő piaci mozgatók

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

2025. dec. 31. 14:37 UTC

Fő piaci mozgatók

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

2025. dec. 31. 21:50 UTC

Piaci beszéd

Basic Materials Roundup: Market Talk

2025. dec. 31. 21:13 UTC

Felvásárlások, összeolvadások, átvételek

10 People to Watch in Wealth Management in 2026 -- Barrons.com

2025. dec. 31. 20:40 UTC

Piaci beszéd

Dollar Posting Its Worst Year Since 2017 -- Market Talk

2025. dec. 31. 20:22 UTC

Piaci beszéd

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

2025. dec. 31. 19:50 UTC

Piaci beszéd

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

2025. dec. 31. 19:31 UTC

Piaci beszéd

Precious Metals Cap Off Record Runs -- Market Talk

2025. dec. 31. 18:50 UTC

Piaci beszéd

Global Equities Roundup: Market Talk

2025. dec. 31. 18:50 UTC

Piaci beszéd

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

2025. dec. 31. 17:17 UTC

Piaci beszéd

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

2025. dec. 31. 17:16 UTC

Fő piaci mozgatók

OwlTing Climbs on Launch of $10M Stock-Buyback Program

2025. dec. 31. 17:15 UTC

Piaci beszéd

Global Commodities Roundup: Market Talk

2025. dec. 31. 17:00 UTC

Felvásárlások, összeolvadások, átvételek

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

2025. dec. 31. 15:57 UTC

Felvásárlások, összeolvadások, átvételek

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

2025. dec. 31. 15:54 UTC

Piaci beszéd

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

2025. dec. 31. 15:02 UTC

Fő piaci mozgatók

Nike Shares Rise After CEO Hill Buys $1M of Shares

2025. dec. 31. 14:40 UTC

Felvásárlások, összeolvadások, átvételek

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

2025. dec. 31. 14:20 UTC

Piaci beszéd

Crude Futures On Track to End the Year With Losses -- Market Talk

2025. dec. 31. 13:46 UTC

Piaci beszéd

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

2025. dec. 31. 13:01 UTC

Eredményjelentés
Felvásárlások, összeolvadások, átvételek

Charles Schwab Is Back on Offense. Its Stock Is a Buy. -- Barrons.com

2025. dec. 31. 11:10 UTC

Piaci beszéd

Copper Remains in Touching Distance of Record Highs -- Market Talk

2025. dec. 31. 10:46 UTC

Piaci beszéd

Euro on Track For Strong Annual Performance -- Market Talk

2025. dec. 31. 10:25 UTC

Piaci beszéd

European Gas Prices Rise But Remain on Track for Heavy Annual Loss -- Market Talk

2025. dec. 31. 10:23 UTC

Piaci beszéd

Chinese Yuan Rises to 31-Month High Against Dollar as Policymakers -- Market Talk

2025. dec. 31. 09:33 UTC

Piaci beszéd

Dollar Set For Worst Annual Performance Since 2017 -- Market Talk

Társak összehasonlítása

Árváltozás

CEVA Inc Előrejelzés

Célár

By TipRanks

67.29% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 36 USD  67.29%

Magas 40 USD

Alacsony 33 USD

5 Wall Street elemző 12 hónapos célárain alapulva a(z)CEVA Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Erős vétel

5 ratings

5

Vétel

0

Tartás

0

Eladás

Technikai pontszám

By Trading Central

20.24 / 26.185Támogatás & ellenállás

Rövid táv

Very Strong Bearish Evidence

Középtáv

Strong Bearish Evidence

Hosszú táv

Bearish Evidence

Hangulat

By Acuity

101 / 403 Rangsor szerint Technológia

Hangulat hírek alapján

Bullish bizonyíték

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag alatti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk CEVA Inc

CEVA, Inc. provides silicon and software IP solutions to semiconductor and original equipment manufacturer (OEM) companies worldwide. Its 5G mobile and infrastructure products include Ceva-XC vector digital signal processors (DSPs) for 5G handsets, 5G RAN, and general-purpose baseband processing; PentaG-RAN, an open ran platform for base station and radio; and PentaG2 - 5G NR modem platform for UE, as well as for non-handset 5G vertical markets, such as fixed wireless access, industry 4.0, robotics, and AR/VR devices. The company's wireless IoT products comprise RivieraWaves' Bluetooth 5dual mode and low energy platforms, RivieraWaves' Wi-Fi platforms, ultra-wide band platforms, and Cellular IoT and RedCap platforms, as well as sense and inference processors and platforms consist of NeuPro-M neural processing unit (NPU) family; SensPro2 sensor hub AI platforms addressing imaging, vision, powertrain, and applications, including DSP processors, AI accelerators, and a software portfolio; and Ceva-BX1 and Ceva-BX2 audio AI DSPs. Its sensing and audio software comprise RealSpace spatial audio software package; WhisPro speech recognition; ClearVox, a voice front-end software package for voice-enabled devices; and CDNN, a neural network graph compiler that enables AI developers to automatically compile, optimize, and run pre-trained networks onto embedded devices. The company's application software IP are licensed primarily to OEMs who embed it in their system on chip designs. It delivers AI DSPs and NPUs in the form of a hardware description language definition; and offers development platforms, software development kits, and software debug tools, which facilitate system design, debug, and software development. The company licenses its technology through a direct sales force. CEVA, Inc. was formerly known as ParthusCeva, Inc. and changed its name to CEVA, Inc. in December 2003. The company was incorporated in 1999 and is headquartered in Rockville, Maryland.
help-icon Live chat